Facebook X (Twitter) Instagram
    Facebook Instagram Threads
    Global BiodefenseGlobal Biodefense
    Subscribe
    • Featured News
    • Funding
    • Directory
    • Jobs
    • Events
    Global BiodefenseGlobal Biodefense
    Public Health

    Some Vaccines Stop Symptomatic Disease, Others Stop You Getting Infected Too

    By Sarah L CaddyJanuary 5, 2021
    Vaccine doses lined up in pre-prepared syringes
    Credit: Damon Grosvenor
    Share
    Facebook LinkedIn Reddit Email

    Vaccines are a marvel of medicine. Few interventions can claim to have saved as many lives. But it may surprise you to know that not all vaccines provide the same level of protection. Some vaccines stop you getting symptomatic disease, but others stop you getting infected too. The latter is known as “sterilizing immunity”. With sterilizing immunity, the virus can’t even gain a toehold in the body because the immune system stops the virus entering cells and replicating.

    There is a subtle yet important difference between preventing disease and preventing infection. A vaccine that “just” prevents disease might not stop you from transmitting the disease to others – even if you feel fine. But a vaccine that provides sterilizing immunity stops the virus in its tracks.

    In an ideal world, all vaccines would induce sterilizing immunity. In reality, it is actually extremely difficult to produce vaccines that stop virus infection altogether. Most vaccines that are in routine use today do not achieve this. For example, vaccines targeting rotavirus, a common cause of diarrhea in infants, are only capable of preventing severe disease. But this has still proven invaluable in controlling the virus. In the US, there has been almost 90% fewer cases of rotavirus-associated hospital visits since the vaccine was introduced in 2006. A similar situation occurs with the current poliovirus vaccines, yet there is hope this virus could be eradicated globally.

    The first SARS-CoV-2 vaccines to be licensed have been shown to be highly effective at reducing disease. Despite this, we don’t yet know whether these vaccines can induce sterilizing immunity. It is expected that data addressing this question will be available from the ongoing vaccine clinical trials soon. Although even if sterilizing immunity is induced initially, this may change over time as immune responses wane and viral evolution occurs.

    Immunity in individuals

    What would a lack of sterilizing immunity mean for those vaccinated with the new COVID vaccines? Quite simply it means that if you encounter the virus after vaccination, you may get infected but show no symptoms. This is because your vaccine-induced immune response is not able to stop every virus particle from replicating.

    It is generally understood that a particular type of antibody known as a “neutralizing antibody” is needed for sterilizing immunity. These antibodies block virus entry into cells and prevent all replication. However, the infecting virus may have to be identical to the vaccine virus in order to induce the perfect antibody.

    Thankfully, our immune responses to vaccines involve many different cells and components of the immune system. Even if the antibody response isn’t optimal, other aspects of immune memory can kick in when the virus invades. These include cytotoxic T cells and non-neutralizing antibodies. Viral replication will be slowed and consequently disease reduced.

    We know this from years of study on influenza vaccines. These vaccines typically induce protection from disease, but not necessarily protection from infection. This is largely due to the different strains of influenza that circulate – a situation that may also occur with SARS-CoV-2. It is reassuring to note that flu vaccines, despite being unable to induce sterilizing immunity, are still extremely valuable at controlling the virus.

    A graph showing the inverse relationship between coronavirus infection severity and protective immunity.
    The inverse relationship between coronavirus infection severity and protective immunity. Sarah L Caddy, Author provided

    Immunity in a population

    In the absence of sterilizing immunity, what effect might SARS-CoV-2 vaccines have on the spread of a virus through a population? If asymptomatic infections are possible after vaccination, there has been concern that SARS-CoV-2 will simply continue to infect as many people as before. Is this possible?

    Asymptomatically infected people typically produce virus at lower levels. Though there is not a perfect relationship, usually more virus equals more disease. Therefore, vaccinated people are less likely to transmit enough virus to cause severe disease. This in turn means that the people getting infected in this situation are going to transmit less virus to the next susceptible person. This has been neatly shown experimentally using a vaccine targeting a different virus in chickens; when only part of a flock was vaccinated, unvaccinated birds still showed milder disease and produced less virus.

    So, while sterilizing immunity is often the ultimate goal of vaccine design, it is rarely achieved. Fortunately, this hasn’t stopped many different vaccines substantially reducing the number of cases of virus infections in the past. By reducing disease levels in individuals, this also reduces virus spread through populations, and this will hopefully bring the current pandemic under control.

    ABOUT THE AUTHOR

    Sarah L Caddy, Clinical Research Fellow in Viral Immunology and Veterinary Surgeon, University of Cambridge. She is a vet and a Wellcome Trust Clinical Research Fellow at the new Cambridge Institute for Therapeutic Immunology and Infectious Disease (CITIID). Sarah’s research focuses on how antibodies can protect us from different virus infections. Sarah is interested in viruses of all species, and holds a Diploma from the American College of Veterinary Microbiology.

    This article is courtesy of The Conversation.

    Editor Pick Medicine-Health Polio Protective Immunity Rotavirus SARS-CoV-2 Science Communication Vaccine Hesitancy Vaccine News
    Share. Facebook LinkedIn Reddit Email
    Previous ArticleDoes SARS-COV-2 Launch a Direct Viral Attack on the Brain?
    Next Article Vaccine Delays Reveal Weak Link in Supply Chains: A Shortage of Workers

    Related Stories

    EPA Developing AMR Risk Framework for Antibacterial and Antifungal Pesticides

    September 29, 2023

    Provide Feedback on Federal DURC Biosafety Oversight of Potential Pandemic Pathogens

    September 24, 2023

    Committee to Examine Transmission and Geographic Spread of Chronic Wasting Disease

    September 24, 2023

    Jurata Thin Film and CastleVax Awarded Grant to Advance Thermostabilized COVID-19 Booster

    September 20, 2023
    News Scan

    Biodefense Headlines – 19 September 2023

    News Scan September 19, 2023

    News highlights on health security threats and countermeasures curated by Global Biodefense This week’s selections include a global survey of gain-of-function research; funding of an mRNA mpox vaccine; Nipah virus outbreak in India; field detection of threat agents with acoustic…

    Upcoming Events

    Oct 3
    Virtual Event Virtual Event
    October 3 - October 5

    OneLab Summit 2023

    Oct 3
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships to Distribute, Dispense, and Administer Medical Countermeasures

    Oct 4
    Virtual Event Virtual Event
    10:00 am - 2:00 pm EDT

    Tunneling Nanotubes and Intracellular Protrusions Workshop

    Oct 12
    Virtual Event Virtual Event
    12:00 pm - 2:00 pm EDT

    Public-Private Partnerships for Acceptance and Uptake of Medical Countermeasures

    View Calendar

    Subscribe to Global Biodefense

    Get the latest news on pathogens and preparedness

    © 2023 Stemar Media Group LLC
    • About
    • Contact
    • Privacy
    • Subscribe

    Type above and press Enter to search. Press Esc to cancel.

    We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy